Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPTAIN: Amoxicillin vs Amoxicillin/Clavulanate for CAP in Older Adults
NCT06229288Phase 3Recruiting
- Sponsor
- CHU de Nantes
- Start
- Apr 2024
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amoxicillin in community acquired pneumonia (CAP), sponsored by CHU de Nantes. Started Apr 2024; status: recruiting.
02
Drugs
amoxicillin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT06229288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06229288.